DNLI R&D Expenses
Denali Therapeutics Inc · R&D Expenses
DNLI R&D Expenses
Latest reported$97.02Mperiod ending
DNLI Quarterly R&D Expenses ($15.58M → $97.02M)
Quarterly R&D Expenses
High-resolution chart · PNG
DNLI r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 97,019,000 | |
| 103,846,000 | |
| 97,905,000 | |
| 101,950,000 | |
| 102,696,000 | |
| 116,227,000 | |
| 99,787,000 | |
| 98,238,000 | |
| 91,399,000 | |
| 107,016,000 | |
| 107,803,000 | |
| 89,737,000 | |
| 97,520,000 | |
| 128,816,000 | |
| 92,111,000 | |
| 87,786,000 | |
| 92,737,000 | |
| 86,098,000 | |
| 67,876,000 | |
| 71,559,000 | |
| 65,711,000 | |
| 60,207,000 | |
| 54,743,000 | |
| 53,704,000 | |
| 53,152,000 | |
| 51,016,000 | |
| 51,551,000 | |
| 52,544,000 | |
| 51,884,000 | |
| 37,403,000 | |
| 39,909,000 | |
| 30,321,000 | |
| 52,134,000 | |
| 20,819,000 | |
| 18,471,000 | |
| 18,515,000 | |
| 19,004,000 | |
| 18,470,000 | |
| 16,730,000 | |
| 27,819,000 | |
| 15,576,500 | |
| 15,576,500 |